FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288033836> ?p ?o ?g. }

• W4288033836 abstract "Avenanthramides are phenolic compounds unique to oats and may contribute to health-promoting properties associated with oat consumption. This study used Xenopus laevis oocytes expressing the glucose transporters, glucose transporter 2 (GLUT2) or sodium-glucose transport protein 1 (SGLT1) and human Caco-2 cells models to investigate the effect of oat avenanthramides on human intestinal glucose transporters. The presence of avenanthramide reduced the glucose uptake in a dose-dependent manner in Caco-2 cells. Glucose uptake in oocytes expressing either GLUT2 or SGLT1 was nullified by oat avenanthramide. There was no significant difference between the inhibition potencies of avenanthramides C and B. Thus, our results suggest that avenanthramides may contribute to the antidiabetic properties of oats. PRACTICAL APPLICATIONS: The present research focus on the antidiabetic properties of avenanthramides, which are unique phenolic compounds found in oats. Inhibiting the activities of the glucose transport proteins expressed in the small intestine is a known strategy to improve the control of postprandial glucose level. We therefore examined the inhibitory effects of avenanthramides on two glucose transporters, glucose transporter 2 and sodium-glucose transport protein 1, predominantly found in the small intestine using the human small intestinal cell model Caco-2 cell line and by heterologously expressing these two transporters in the Xenopus laevis oocytes. Based on our results, we have confirmed for the first time that the glucose uptake is indeed inhibited by the presence of avenanthramides, suggesting the possibility of incorporating avenanthramides in foods to enhance postprandial glucose response, and ultimately improve the management of diabetes. Therefore, future research could consider utilizing this evidence in the development of diabetic-friendly functional foods or nutraceuticals containing avenanthramides." @default.
• W4288033836 created "2022-07-27" @default.
• W4288033836 creator A5008981045 @default.
• W4288033836 creator A5009021106 @default.
• W4288033836 creator A5022865272 @default.
• W4288033836 creator A5038263071 @default.
• W4288033836 creator A5039853405 @default.
• W4288033836 creator A5066244214 @default.
• W4288033836 date "2022-07-27" @default.
• W4288033836 modified "2023-10-14" @default.
• W4288033836 title "The inhibition of intestinal glucose absorption by oat‐derived avenanthramides" @default.
• W4288033836 cites W1528581371 @default.
• W4288033836 cites W1755208670 @default.
• W4288033836 cites W1965509967 @default.
• W4288033836 cites W1995652013 @default.
• W4288033836 cites W2002875751 @default.
• W4288033836 cites W2011638123 @default.
• W4288033836 cites W2044161488 @default.
• W4288033836 cites W2065792257 @default.
• W4288033836 cites W2074503802 @default.
• W4288033836 cites W2077793391 @default.
• W4288033836 cites W2103869657 @default.
• W4288033836 cites W2129561108 @default.
• W4288033836 cites W2133813606 @default.
• W4288033836 cites W2134836351 @default.
• W4288033836 cites W2135984099 @default.
• W4288033836 cites W2159156567 @default.
• W4288033836 cites W21727487 @default.
• W4288033836 cites W2190389119 @default.
• W4288033836 cites W2264715249 @default.
• W4288033836 cites W2287639915 @default.
• W4288033836 cites W2298073903 @default.
• W4288033836 cites W2313724273 @default.
• W4288033836 cites W2411234506 @default.
• W4288033836 cites W2517056952 @default.
• W4288033836 cites W2560872530 @default.
• W4288033836 cites W2788819797 @default.
• W4288033836 cites W2889302606 @default.
• W4288033836 cites W2964330776 @default.
• W4288033836 cites W3000711945 @default.
• W4288033836 cites W3136677841 @default.
• W4288033836 cites W3155909253 @default.
• W4288033836 cites W3157801481 @default.
• W4288033836 cites W4236190354 @default.
• W4288033836 cites W4237649909 @default.
• W4288033836 doi "https://doi.org/10.1111/jfbc.14324" @default.
• W4288033836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35892210" @default.
• W4288033836 hasPublicationYear "2022" @default.
• W4288033836 type Work @default.
• W4288033836 citedByCount "2" @default.
• W4288033836 countsByYear W42880338362023 @default.
• W4288033836 crossrefType "journal-article" @default.
• W4288033836 hasAuthorship W4288033836A5008981045 @default.
• W4288033836 hasAuthorship W4288033836A5009021106 @default.
• W4288033836 hasAuthorship W4288033836A5022865272 @default.
• W4288033836 hasAuthorship W4288033836A5038263071 @default.
• W4288033836 hasAuthorship W4288033836A5039853405 @default.
• W4288033836 hasAuthorship W4288033836A5066244214 @default.
• W4288033836 hasConcept C104317684 @default.
• W4288033836 hasConcept C134018914 @default.
• W4288033836 hasConcept C149011108 @default.
• W4288033836 hasConcept C161573976 @default.
• W4288033836 hasConcept C185592680 @default.
• W4288033836 hasConcept C2777866211 @default.
• W4288033836 hasConcept C2777901630 @default.
• W4288033836 hasConcept C2778199505 @default.
• W4288033836 hasConcept C2779306644 @default.
• W4288033836 hasConcept C2779535977 @default.
• W4288033836 hasConcept C55493867 @default.
• W4288033836 hasConcept C555293320 @default.
• W4288033836 hasConcept C86803240 @default.
• W4288033836 hasConceptScore W4288033836C104317684 @default.
• W4288033836 hasConceptScore W4288033836C134018914 @default.
• W4288033836 hasConceptScore W4288033836C149011108 @default.
• W4288033836 hasConceptScore W4288033836C161573976 @default.
• W4288033836 hasConceptScore W4288033836C185592680 @default.
• W4288033836 hasConceptScore W4288033836C2777866211 @default.
• W4288033836 hasConceptScore W4288033836C2777901630 @default.
• W4288033836 hasConceptScore W4288033836C2778199505 @default.
• W4288033836 hasConceptScore W4288033836C2779306644 @default.
• W4288033836 hasConceptScore W4288033836C2779535977 @default.
• W4288033836 hasConceptScore W4288033836C55493867 @default.
• W4288033836 hasConceptScore W4288033836C555293320 @default.
• W4288033836 hasConceptScore W4288033836C86803240 @default.
• W4288033836 hasFunder F4320334595 @default.
• W4288033836 hasIssue "10" @default.
• W4288033836 hasLocation W42880338361 @default.
• W4288033836 hasLocation W42880338362 @default.
• W4288033836 hasOpenAccess W4288033836 @default.
• W4288033836 hasPrimaryLocation W42880338361 @default.
• W4288033836 hasRelatedWork W1993812967 @default.
• W4288033836 hasRelatedWork W2008307864 @default.
• W4288033836 hasRelatedWork W2034982671 @default.
• W4288033836 hasRelatedWork W2061301876 @default.
• W4288033836 hasRelatedWork W2078500483 @default.
• W4288033836 hasRelatedWork W2082464633 @default.
• W4288033836 hasRelatedWork W2115427222 @default.
• W4288033836 hasRelatedWork W2157951779 @default.
• W4288033836 hasRelatedWork W2296250523 @default.
• W4288033836 hasRelatedWork W369173270 @default.

• next